GRP and neoplasm: Interestingly, Wang et al. recently reported on a series of bombesin analogues modified at the C-terminus, which resulted in high activity levels in the tumor (~16 %ID/g) and low levels in the pancreas (~2 %ID/g) at 1 h p.i. for one compound ([68Ga]Ga-TacsBOMB5) [26].